Vimarsana
Biggest News Aggregation in the World

Roche Holding Chart News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Roche Holding Chart. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Roche Holding Chart Today - Breaking & Trending Today

FDA Approves Genentech's Vabysmo for the Treatment of Retinal Vein Occlusion (RVO) Seite 1 - Vimarsana News

FDA Approves Genentech's Vabysmo for the Treatment of Retinal Vein Occlusion (RVO) Seite 1

27.10.2023 - Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved Vabysmo (faricimab-svoa) for the treatment of macular edema following retinal vein occlusion (RVO). RVO ... Seite 1

Genentech's Alecensa Reduces the Risk of Disease Recurrence or Death by an Unprecedented 76% in People With ALK-Positive Early-Stage Non-Small Cell Lung Cancer Seite 1 - Vimarsana News

Genentech's Alecensa Reduces the Risk of Disease Recurrence or Death by an Unprecedented 76% in People With ALK-Positive Early-Stage Non-Small Cell Lung Cancer Seite 1

18.10.2023 - Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced results from the primary analysis of the Phase III ALINA study demonstrating a statistically significant and clinically meaningful improvement in disease-free ... Seite 1